349 related articles for article (PubMed ID: 4042422)
21. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
Suthanthiran M; Williams PS; Solomon SD; Rubin AL; Stenzel KH
J Clin Invest; 1984 Dec; 74(6):2263-71. PubMed ID: 6392343
[TBL] [Abstract][Full Text] [Related]
22. Natural killer activity and antibody-dependent cellular cytotoxicity in patients with non-Hodgkin's lymphoma.
Metha BA; Advani SH; Nadkarni SJ
Neoplasma; 1988; 35(1):61-8. PubMed ID: 3352838
[TBL] [Abstract][Full Text] [Related]
23. Relationship between immune system and gram-negative bacteria. II. Natural killer cytotoxicity of Salmonella minnesota Rb 345-unbound human peripheral blood lymphocytes.
Antonaci S; Jirillo E; Ventura MT; Michalek SM; Bonomo L; McGhee JR
J Immunol; 1984 Aug; 133(2):729-33. PubMed ID: 6234358
[TBL] [Abstract][Full Text] [Related]
24. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.
Lanier LL; Le AM; Phillips JH; Warner NL; Babcock GF
J Immunol; 1983 Oct; 131(4):1789-96. PubMed ID: 6225799
[TBL] [Abstract][Full Text] [Related]
25. Natural killer activity and NK cytotoxic factors in peripheral blood and lymph node cells from non-Hodgkin's lymphoma patients.
Nadkarni JJ; Mehta BA; Koppikar SB; Soman CS; Shrikhande SS; Advani SH
Neoplasma; 1989; 36(6):701-8. PubMed ID: 2615873
[TBL] [Abstract][Full Text] [Related]
26. The use of VEP13 monoclonal antibody for definition of natural killer cells: spontaneous killer cells directed against fresh human leukaemia cells carry the VEP13 antigen.
Ziegler-Heitbrock HW; Fütterer A; Rumpold H; Kraft D; Munker R; Riethmüller G
Clin Exp Immunol; 1984 Nov; 58(2):470-7. PubMed ID: 6333947
[TBL] [Abstract][Full Text] [Related]
27. Natural killer lymphocytes in hairy cell leukemia: presence of phenotypically identifiable cells with defective functional activity.
Smith BR; Rosenthal DS; Ault KA
Exp Hematol; 1985 Mar; 13(3):189-93. PubMed ID: 3884356
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies against SSEA-1 antigen: binding properties and inhibition of human natural killer cell activity against target cells bearing SSEA-1 antigen.
Harris JF; Chin J; Jewett MA; Kennedy M; Gorczynski RM
J Immunol; 1984 May; 132(5):2502-9. PubMed ID: 6143780
[TBL] [Abstract][Full Text] [Related]
29. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
30. Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells.
van de Griend RJ; van Krimpen BA; Ronteltap CP; Bolhuis RL
J Immunol; 1984 Jun; 132(6):3185-91. PubMed ID: 6233369
[TBL] [Abstract][Full Text] [Related]
31. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays.
Gregory CD; Lee H; Rees GB; Scott IV; Shah LP; Golding PR
Clin Exp Immunol; 1985 Oct; 62(1):121-7. PubMed ID: 3864569
[TBL] [Abstract][Full Text] [Related]
32. A monoclonal antibody against a surface antigen shared by human large granular lymphocytes and granulocytes.
Rumpold H; Kraft D; Obexer G; Böck G; Gebhart W
J Immunol; 1982 Oct; 129(4):1458-64. PubMed ID: 6180009
[TBL] [Abstract][Full Text] [Related]
33. A large subpopulation of lymphocytes with T helper phenotype (Leu-3/T4+) exhibits the property of binding to NK cell targets and granular lymphocyte morphology.
Velardi A; Grossi CE; Cooper MD
J Immunol; 1985 Jan; 134(1):58-64. PubMed ID: 3155472
[TBL] [Abstract][Full Text] [Related]
34. Reduced number of natural killer cells in patients with pathological hyperprolactinemia.
Gerli R; Rambotti P; Nicoletti I; Orlandi S; Migliorati G; Riccardi C
Clin Exp Immunol; 1986 May; 64(2):399-406. PubMed ID: 3091304
[TBL] [Abstract][Full Text] [Related]
35. T cell nature and heterogeneity of recognition structures of human natural killer (NK) cells.
Fast LD; Beatty P; Hansen JA; Newman W
J Immunol; 1983 Nov; 131(5):2404-10. PubMed ID: 6415167
[TBL] [Abstract][Full Text] [Related]
36. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
[TBL] [Abstract][Full Text] [Related]
37. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
38. Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon.
Lotzová E; Savary CA; Quesada JR; Gutterman JU; Hersh EM
J Natl Cancer Inst; 1983 Nov; 71(5):903-10. PubMed ID: 6580490
[TBL] [Abstract][Full Text] [Related]
39. [Cytotoxicity of effector cells of the peripheral blood, lymph nodes and spleen in Hodgkin's disease].
Blokhina NG; Bykovskaia SN; Kharabadze MV; Kupriianova TA; Agafonov VA
Biull Eksp Biol Med; 1989 Nov; 108(11):600-3. PubMed ID: 2633827
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic activity of lymphocytes from patients with Hodgkin's disease.
Holm G; Björkholm M; Mellstedt H; Johansson B
Clin Exp Immunol; 1975 Sep; 21(3):376-83. PubMed ID: 1081933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
